CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Dec. 31, 2025	Mar. 31, 2025
Current assets:
Cash and cash equivalents	$ 122,951	$ 111,119
Short-term investments	146,186	372,685
Research and development incentives receivable	2,955	3,725
Prepaid expenses and other current assets	8,262	8,351
Total current assets	280,354	495,880
Property, plant and equipment, net	13,847	13,739
Restricted cash	1,704	1,703
Other non-current assets	1,200	1,200
Right-of-use asset - operating leases	3,498	3,998
Right-of-use asset - financing leases	32,987	34,808
Total assets	333,590	551,328
Current liabilities:
Accounts payable	5,647	12,463
Accrued expenses and other current liabilities	40,365	45,916
Operating lease liabilities, current	1,213	1,184
Financing lease liabilities, current	2,862	2,799
Total current liabilities	50,087	62,362
Operating lease liabilities, non-current	2,514	3,076
Financing lease liabilities, non-current	22,129	22,729
Long term debt, net of discount	47,628	46,377
Other liabilities, non-current	693	941
Total liabilities	123,051	135,485
Commitments and contingencies (Note 14)
Stockholders' equity
Common stock, $0.001 par value; 150,000,000 shares authorized as of December 31, 2025 and March 31, 2025; 79,631,167 and 77,085,024 shares issued and outstanding as of December 31, 2025 and March 31, 2025, respectively	79	77
Additional paid-in capital	1,394,198	1,358,897
Accumulated deficit	(1,189,302)	(948,579)
Accumulated other comprehensive income	5,564	5,448
Total stockholders' equity	210,539	415,843
Total liabilities and stockholders' equity	$ 333,590	$ 551,328